Artificial Intelligence

Voxel's AI transforms cameras into proactive safety systems, slashing injuries by 91% and proving that workplace safety is a powerful form of preventative care.

One firm is ditching market predictions for a new approach: debunking costly myths. Here’s why this matters for healthcare leaders and investors.

Huntington Bank appoints veteran strategist Marc Dizard as CIO, signaling a major push to modernize its investment platform and challenge regional rivals.

A new law requires work verification for millions on Medicaid. One tech firm has a solution, but can its AI bridge the gap or widen the access divide?

Formerly Fairmatic, LEEO launches with a new CEO and VC backing to tackle the broken commercial auto market with AI. Can its data-driven model succeed?

Klarna is moving beyond payments to build the data layer for AI shopping. Will its new open protocol revolutionize retail or just shift the balance of power?

Anixa Biosciences now fully controls its breast cancer vaccine after promising Phase 1 data. What does this strategic move mean for investors and medicine?

Odysight.ai's new sensors offer a live video feed from inside hot, oil-filled machinery, a breakthrough poised to transform industrial predictive maintenance.

As cargo theft surges, one company’s AI-powered security is becoming the new standard for protecting the nation’s vital logistics and its drivers.

Beyond the factory, China's manufacturers are now tech pioneers. The MEI Awards reveal a strategic shift that is reshaping global markets and supply chains.

Rail Vision just secured a key European patent for its AI collision avoidance tech. Is this IP fortress enough to challenge giants and define the future of rail?

A new FDA clearance for its AI software enhances Hyperfine's portable MRI, positioning it to disrupt the lucrative stroke diagnostics market. Here's why.

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

The hiring of M&A veteran Eric Olson as Chief Corporate Development Officer signals REI Systems’ aggressive new strategy to conquer the national security market.

A new drug for a leading cause of blindness missed its primary goal, yet its unique ability to improve vision offers new hope for millions of patients.

Talen Energy unveils a major executive overhaul and a novel compensation plan, signaling a strategic pivot to dominate the energy-hungry AI data center market.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.

A pivotal trial success in lupus for BTK inhibitor orelabrutinib not only offers new hope for patients but also validates Zenas BioPharma's strategy.

The crypto giant reports massive growth, but a pivot to AI, operational fires, and rising debt reveal a risky strategy to reshape global computing power.